SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (69)1/8/1999 1:54:00 PM
From: Biomaven  Read Replies (1) of 3158
 
Well I guess OSIP agrees with the thesis of this thread, which is no surprise. The open question of course is whether the hunters agree.

Note that this "shareholder rights" plan (it should of course be called a "management rights" plan) is probably not addressed to collaborators like Pfizer, which is already a substantial shareholder (they bought 1/2 million shares back in 1986) or like HMR (1 1/2 million shares). These purchase agreements typically contain "standstill" clauses that prevent the acquisition of more than a certain percentage ownership by the partner.

Interesting to see what the H&Q conference next week brings. We should get some good news from the conference (as companies historically have hoarded some good news for it), and the sector is also due for some FDA approvals (LGND, DEPO, SEPR). The burning question is whether people are going to see good news as a selling opportunity or a buying one.

Peer
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News